BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12483034)

  • 21.
    Ünsal H; Şahiner ÜM; Soyer Ö; Şekerel BE
    Turk J Med Sci; 2023; 53(5):1262-1270. PubMed ID: 38813017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and expression of a major allergen from Cupressus arizonica pollen, Cup a 3, a PR-5 protein expressed under polluted environment.
    Cortegano I; Civantos E; Aceituno E; del Moral A; López E; Lombardero M; del Pozo V; Lahoz C
    Allergy; 2004 May; 59(5):485-90. PubMed ID: 15080828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can component-based microarray replace fluorescent enzimoimmunoassay in the diagnosis of grass and cypress pollen allergy?
    Cabrera-Freitag P; Goikoetxea MJ; Beorlegui C; Gamboa P; Gastaminza G; Fernández-Benítez M; Ferrer M; Blanca M; Sanz ML
    Clin Exp Allergy; 2011 Oct; 41(10):1440-6. PubMed ID: 21749500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactivity between major IgE core epitopes on Cry j 2 allergen of Japanese cedar pollen and relevant sequences on Cha o 2 allergen of Japanese cypress pollen.
    Miyaji K; Okamoto N; Saito A; Yasueda H; Takase Y; Shimakura H; Saito S; Sakaguchi M
    Allergol Int; 2016 Jul; 65(3):286-92. PubMed ID: 26916996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular cloning of major allergen from Cupressus arizonica pollen: Cup a 1.
    Aceituno E; Del Pozo V; Mínguez A; Arrieta I; Cortegano I; Cárdaba B; Gallardo S; Rojo M; Palomino P; Lahoz C
    Clin Exp Allergy; 2000 Dec; 30(12):1750-8. PubMed ID: 11122214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a 7 kDa pollen allergen belonging to the gibberellin-regulated protein family from three Cupressaceae species.
    Ehrenberg AE; Klingebiel C; Östling J; Larsson H; Mattsson L; Vitte J; Lidholm J
    Clin Exp Allergy; 2020 Aug; 50(8):964-972. PubMed ID: 32506709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a polygalacturonase (Cup s 2) as the major CCD-bearing allergen in Cupressus sempervirens pollen.
    Shahali Y; Sutra JP; Hilger C; Swiontek K; Haddad I; Vinh J; Guilloux L; Charpin D; Sénéchal H; Poncet P
    Allergy; 2017 Nov; 72(11):1806-1810. PubMed ID: 28439939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cypress pollen allergy].
    Charpin D; Calleja M; Pichot C; Penel V; Hugues B; Poncet P
    Rev Mal Respir; 2013 Dec; 30(10):868-78. PubMed ID: 24314710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of air pollution on cup a 3 allergen in Cupressus arizonica pollen grains.
    Suárez-Cervera M; Castells T; Vega-Maray A; Civantos E; del Pozo V; Fernández-González D; Moreno-Grau S; Moral A; López-Iglesias C; Lahoz C; Seoane-Camba JA
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):57-66. PubMed ID: 18681086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of cypress gibberellin-regulated protein: Analysis of its structural features and IgE binding competition with homologous allergens.
    Tuppo L; Alessandri C; Giangrieco I; Ciancamerla M; Rafaiani C; Tamburrini M; Ciardiello MA; Mari A
    Mol Immunol; 2019 Oct; 114():189-195. PubMed ID: 31376732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerability and Immunological Effect of Short Up-Dosing Immunotherapy With 2 Standardized Native Allergen Extracts Derived From the Pollen of Salsola kali and Cupressus arizonica.
    González Delgado P; Ibáñez Echevarría E; Antón Gironés M; Rodríguez Mosquera M; Alonso Díaz de Durana MD; Prieto Montaño P; Marín de Pablo A; Fernández-Rivas M
    J Investig Allergol Clin Immunol; 2018 Apr; 28(2):128-131. PubMed ID: 29661740
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgE crossreactivity between mugwort pollen (Artemisia vulgaris) and hazelnut (Abellana nux) in sera from patients with sensitivity to both extracts.
    Caballero T; Pascual C; García-Ara MC; Ojeda JA; Martín-Esteban M
    Clin Exp Allergy; 1997 Oct; 27(10):1203-11. PubMed ID: 9383261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arizona cypress (Cupressus arizonica) pollen allergens. Identification of cross-reactive periodate-resistant and -sensitive epitopes with monoclonal antibodies.
    Barletta B; Tinghino R; Corinti S; Afferni C; Iacovacci P; Mari A; Pini C; Di Felice G
    Allergy; 1998 Jun; 53(6):586-93. PubMed ID: 9689340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Instability of the structure and allergenic protein content in Arizona cypress pollen.
    Shahali Y; Pourpak Z; Moin M; Mari A; Majd A
    Allergy; 2009 Dec; 64(12):1773-9. PubMed ID: 19624556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Allergy to cypress pollen: preparation of a reference and standardization extract in vivo].
    Leduc V; Charpin D; Aparicio C; Veber C; Guérin L
    Allerg Immunol (Paris); 2000 Mar; 32(3):101-3. PubMed ID: 10815236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refolding of the Cupressus arizonica major pollen allergen Cup a1.02 overexpressed in Escherichia coli.
    Rea G; Iacovacci P; Ferrante P; Zelli M; Brunetto B; Lamba D; Boffi A; Pini C; Federico R
    Protein Expr Purif; 2004 Oct; 37(2):419-25. PubMed ID: 15358365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunochemical Characterization of Salix alba (S. alba) Pollen Allergens and Evaluation of the Cross-Reactivity Pattern with Common Allergenic Pollen Grains.
    Baghersad A; Shams MH; Shahsavar F; Sohrabi SM; Varzi AM; Baharvand PA; Eskandari N; Darestani NG; Sereshki HA; Doosti F; Assarehzadegan MA
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110953. PubMed ID: 37757632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study.
    Vervloet D; Birnbaum J; Laurent P; Hugues B; Fardeau MF; Massabie-Bouchat YP; Aferiat-Derome A; André C
    Int Arch Allergy Immunol; 2007; 142(3):239-46. PubMed ID: 17114889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.